FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Teva Pharmaceuticals CARBOplatin Injection Recall

CARBOplatin Injection, 600 mg/60ml, MultiDose, Rx only, Teva Parenteral Medicines, Inc

Teva Pharmaceuticals USA, Inc. · Sellersville, PA

Risk level
Class II
Reported by FDA
Sep 11, 2013
Recall ID
D-928-2013
Check your lot numberHow we source this data

Summary

Teva Pharmaceuticals recalled CARBOplatin Injection starting Aug 13, 2013. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-928-2013 on Sep 11, 2013. Reason: Lack of Assurance of Sterility: The required reduction of endotoxin was not met during the annual revalidation of the vial washer. Status: Terminated.

Why it was recalled

Lack of Assurance of Sterility: The required reduction of endotoxin was not met during the annual revalidation of the vial washer.

Product description

CARBOplatin Injection, 600 mg/60ml, MultiDose, Rx only, Teva Parenteral Medicines, Inc., Irvine, CA 92618 NDC 0703-3249-11

Lot numbers, UPCs & expiration codes

Lot 31314458B, 31314459B exp.08/14, 31315794 exp. 10/14, 31315982B exp.11/14

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-928-2013
Classification
Class II
Status
Terminated
Recall initiated
Aug 13, 2013
FDA report date
Sep 11, 2013
Quantity
780 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Teva Pharmaceuticals USA, Inc.

Original FDA data

Every field from FDA enforcement report D-928-2013, exactly as published.

Show all FDA fields
City
Sellersville
State
PA
Status
Terminated
Country
United States
Event ID
65959
Address
650 Cathill Rd
Code information
Lot 31314458B, 31314459B exp.08/14, 31315794 exp. 10/14, 31315982B exp.11/14
Postal code
18960-1512
Report date
Sep 11, 2013
Product type
Drugs
Recall number
D-928-2013
Classification
Class II
Recalling firm
Teva Pharmaceuticals USA, Inc.
Product quantity
780 vials
Termination date
Aug 27, 2014
Reason for recall
Lack of Assurance of Sterility: The required reduction of endotoxin was not met during the annual revalidation of the vial washer.
Voluntary / mandated
Voluntary: Firm initiated
Product description
CARBOplatin Injection, 600 mg/60ml, MultiDose, Rx only, Teva Parenteral Medicines, Inc., Irvine, CA 92618 NDC 0703-3249-11
Distribution pattern
Nationwide
Recall initiation date
Aug 13, 2013
Initial firm notification
Letter
Center classification date
Sep 3, 2013

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-928-2013, published Sep 11, 2013. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls